David A. Sandham

Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy

David A. Sykes, Michelle Bradley, Darren Riddy et al. · Molecular Pharmacology · 2016 · 67 citations · Full text

A convergent synthesis of the renin inhibitor CGP60536B

David A. Sandham, Roger Taylor, John Carey et al. · Tetrahedron Letters · 2000 · 51 citations

Combinatorial Chemistry, Medicine, Renin Inhibitor Cgp60536b +2

7-Azaindole-3-acetic acid derivatives: Potent and selective CRTh2 receptor antagonists

David A. Sandham, Claire Adcock, Kamlesh Bala et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 43 citations · Full text

Medicine, Mechanism Of Action, Pharmacological Agent +4

Rhodium promoted isomerisation of allylic alkoxides: a new method for enolate anion formation

Lewis Gazzard, William B. Motherwell, David A. Sandham · Journal of the Chemical Society Perkin Transactions 1 · 1999 · 42 citations

Chemical Engineering, Enolate Formation, Engineering +12

Uncoupling the Structure–Activity Relationships of β2 Adrenergic Receptor Ligands from Membrane Binding

Callum J. Dickson, Viktor Horn̆ák, Camilo Velez‐Vega et al. · Journal of Medicinal Chemistry · 2016 · 36 citations · Full text